JP2024521818A5 - - Google Patents
Info
- Publication number
- JP2024521818A5 JP2024521818A5 JP2023573154A JP2023573154A JP2024521818A5 JP 2024521818 A5 JP2024521818 A5 JP 2024521818A5 JP 2023573154 A JP2023573154 A JP 2023573154A JP 2023573154 A JP2023573154 A JP 2023573154A JP 2024521818 A5 JP2024521818 A5 JP 2024521818A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- ethyl
- amino
- pyridazine
- dione
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163193831P | 2021-05-27 | 2021-05-27 | |
| US63/193,831 | 2021-05-27 | ||
| US202163226980P | 2021-07-29 | 2021-07-29 | |
| US63/226,980 | 2021-07-29 | ||
| PCT/US2022/031133 WO2022251497A1 (en) | 2021-05-27 | 2022-05-26 | Heterocyclic compounds and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024521818A JP2024521818A (ja) | 2024-06-04 |
| JP2024521818A5 true JP2024521818A5 (https=) | 2025-06-03 |
Family
ID=84229207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023573154A Pending JP2024521818A (ja) | 2021-05-27 | 2022-05-26 | ヘテロ環式化合物およびその使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240279221A1 (https=) |
| EP (1) | EP4346815A4 (https=) |
| JP (1) | JP2024521818A (https=) |
| KR (1) | KR20240013792A (https=) |
| WO (1) | WO2022251497A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023116902A1 (zh) * | 2021-12-23 | 2023-06-29 | 北京望实智慧科技有限公司 | Sos1抑制剂 |
| US20250154147A1 (en) | 2022-01-14 | 2025-05-15 | Jazz Pharmaceuticals Ireland Limited | Novel amine-substituted phthalazines and derivatives as sos1 inhibitors |
| IL314594A (en) * | 2022-02-04 | 2024-09-01 | Schr?Dinger Inc | Heterocyclic compounds and methods of use |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080039444A1 (en) * | 2006-04-20 | 2008-02-14 | Glaxo Group Limited | Compounds |
| US20100184770A1 (en) * | 2006-12-20 | 2010-07-22 | Glaxo Group Limited | Compounds |
| DK2986611T3 (da) * | 2013-04-18 | 2019-05-06 | Shanghai Fochon Pharmaceutical Co Ltd | Bestemte proteinkinaseinhibitorer |
| CN107074824B (zh) * | 2014-09-05 | 2021-01-08 | 基因泰克公司 | 作为用于治疗癌症的pcaf和gcn5抑制剂的式(i)的酞嗪衍生物 |
| HRP20230400T1 (hr) * | 2017-12-21 | 2023-06-23 | Boehringer Ingelheim International Gmbh | Benzilamino supstituirani piridopirimidinoni i derivati kao inhibitori sos1 |
| WO2023116902A1 (zh) * | 2021-12-23 | 2023-06-29 | 北京望实智慧科技有限公司 | Sos1抑制剂 |
| WO2023143147A1 (zh) * | 2022-01-28 | 2023-08-03 | 上海优理惠生医药有限公司 | 一种哒嗪并吡啶酮类化合物、其药物组合物及应用 |
-
2022
- 2022-05-26 EP EP22812161.2A patent/EP4346815A4/en not_active Withdrawn
- 2022-05-26 US US18/564,291 patent/US20240279221A1/en active Pending
- 2022-05-26 JP JP2023573154A patent/JP2024521818A/ja active Pending
- 2022-05-26 KR KR1020237044751A patent/KR20240013792A/ko active Pending
- 2022-05-26 WO PCT/US2022/031133 patent/WO2022251497A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024521818A5 (https=) | ||
| JP2025535046A (ja) | Ｋｒａｓ ｇ１２ｃ変異タンパク質の複素環阻害剤及びその使用 | |
| RU2473549C2 (ru) | Пиримидиновые соединения, композиции и способы применения | |
| EP2101759B1 (en) | Methods of using mek inhibitors | |
| JP5808793B2 (ja) | キナーゼ調節のための化合物および方法、ならびにそれらの適応症 | |
| JP2025535045A (ja) | Ｋｒａｓ ｇ１２ｃ変異タンパク質の複素環阻害剤及びその使用 | |
| CN118974055A (zh) | 作为突变kras蛋白抑制剂的喹唑啉化合物及其用途 | |
| HRP20240994T1 (hr) | Spoj inhibitora jak i njegova uporaba | |
| JP2012528178A5 (https=) | ||
| JP2019535664A5 (https=) | ||
| CA2984259A1 (en) | Combinations of inhibitors of irak4 with inhibitors of btk | |
| RU2011152973A (ru) | Индуцирующие апоптоз средства для лечения злокачественной опухоли и иммунных и аутоиммунных заболеваний | |
| JP2022500402A5 (https=) | ||
| JP2019504821A5 (https=) | ||
| JP2018044008A5 (https=) | ||
| JP2019523233A5 (https=) | ||
| RU2015112580A (ru) | Ингибиторные соединения | |
| JP2013528204A5 (https=) | ||
| HRP20130106T1 (hr) | Imidazotriazini i imidazopirimidini kao inhibitori kinaze | |
| CN102548992A (zh) | 作为syk激酶抑制剂的2,7-萘啶-1-酮衍生物 | |
| JP2010510319A5 (https=) | ||
| JP2012501312A5 (https=) | ||
| JP2010523576A5 (https=) | ||
| JP2009520019A (ja) | ピリミジン誘導体 | |
| JP2016518372A5 (https=) |